MMSI logo

Merit Medical Systems, Inc. Stock Price

NasdaqGS:MMSI Community·US$5.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

MMSI Share Price Performance

US$87.18
3.63 (4.34%)
US$89.55
Fair Value
US$87.18
3.63 (4.34%)
2.6% undervalued intrinsic discount
US$89.55
Fair Value
Price US$87.18
AnalystConsensusTarget US$89.55
AnalystLowTarget US$83.00
AnalystHighTarget US$110.00

MMSI Community Narratives

·
Fair Value US$89.55 2.6% undervalued intrinsic discount

Global Aging And Healthcare Demand Will Expand Medical Procedures

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$83 5.0% overvalued intrinsic discount

Tariffs And OEM Volatility Will Pressure Margins Yet Long Term Procedure Demand Will Support Progress

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$110 20.7% undervalued intrinsic discount

Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$89.55
2.6% undervalued intrinsic discount
Revenue
6.08% p.a.
Profit Margin
11.61%
Future PE
31.53x
Price in 2029
US$110.49

Trending Discussion

No trending discussion available.

Updated Narratives

MMSI logo

MMSI: Strong Q2 Execution And 2026 Guidance Will Test Earnings Power

Fair Value: US$83 5.0% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MMSI logo

MMSI: Lower P/E Assumptions Will Set Up Future Repricing Potential

Fair Value: US$110 20.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MMSI logo

MMSI: Discount Rate Reset And 2026 Guidance Will Support Share Price

Fair Value: US$89.55 2.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with proven track record.

0 Risks
3 Rewards

Merit Medical Systems, Inc. Key Details

US$1.6b

Revenue

US$797.1m

Cost of Revenue

US$781.7m

Gross Profit

US$636.2m

Other Expenses

US$145.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.44
49.51%
9.22%
43.8%
View Full Analysis

About MMSI

Founded
1987
Employees
7500
CEO
Martha Aronson
WebsiteView website
www.merit.com

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Recent MMSI News & Updates

Narrative Update Jul 31

MMSI: Strong Q2 Execution And 2026 Guidance Will Test Earnings Power

Merit Medical Systems' analyst fair value estimate has increased from $74.00 to $83.00, in line with higher Street price targets after analysts highlighted a strong Q2 report, a rebound in organic growth, raised 2026 guidance and expectations for improved margins and earnings power. Analyst Commentary The recent research coverage on Merit Medical Systems centers on a stronger Q2 print, higher 2026 guidance and a series of upward price target revisions.

Recent updates

No updates